Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.345 USD | -3.87% | -6.08% | -47.43% |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
05-09 | Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight | MT |